Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00218140 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1
A Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00218140: Completed Phase 2 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00218140 is a Phase 2 study that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00218140, a Phase 2 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
Women typically have a more difficult time quitting smoking than men. Little research has been done to understand the differences between men and women that may cause this distinction. This study will assess whether the reduced effectiveness of nicotine replacement therapy in women is caused by gender differences in the withdrawal suppression induced by nicotine replacement therapy.
Interventions
- DRUG nicotine transdermal system
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2005-04 |
| Phase | Phase 2 |
What the finished NCT00218140 record still lists
NCT00218140 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which nicotine transdermal system is the first listed.
NCT00218140 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00218140 about?
NCT00218140 is a clinical study titled "Effectiveness of the Nicotine Patch in Suppressing Nicotine Withdrawal Symptoms in Women Versus Men - 1". Women typically have a more difficult time quitting smoking than men. Little research has been done to understand the differences between men and women that may cause this distinction. This study will assess whether the reduced effectiveness of nicotine replacement therapy in women is caused by gend...
What is the current status of trial NCT00218140?
This trial is currently completed. It is a Phase 2 study. Estimated completion is 2005-04.
What interventions are being tested in trial NCT00218140?
The interventions under investigation include: nicotine transdermal system (DRUG).
Who is sponsoring clinical trial NCT00218140?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.